These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 37574436)
1. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma. Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436 [TBL] [Abstract][Full Text] [Related]
2. miRNA-27b-3p, let-7f-5p and miRNA-142-5p can be Used in a Novel Serum Diagnostic Panel for Clear Cell Renal Cell Carcinoma. He T; Lu C; Gong W; Ge Z; Li R; Li X; Sun C; Li W; Long Q; Liu Q; Lai Y Front Biosci (Landmark Ed); 2024 May; 29(5):186. PubMed ID: 38812297 [TBL] [Abstract][Full Text] [Related]
3. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma. Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891 [TBL] [Abstract][Full Text] [Related]
4. Inverse correlation of miR-27a-3p and CDH5 expression serves as a diagnostic biomarker of proliferation and metastasis of clear cell renal carcinoma. Wang Y; Zhou X; Han P; Lu Y; Zhong X; Yang Y; Li D; Liu D; Li Q; Pan N; Mo Y; Luo W; Li P; Zhou X; Liudmila M Pathol Res Pract; 2021 Apr; 220():153393. PubMed ID: 33740544 [TBL] [Abstract][Full Text] [Related]
5. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
6. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma. Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711 [TBL] [Abstract][Full Text] [Related]
7. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data. Guan L; Tan J; Li H; Jin X Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611 [TBL] [Abstract][Full Text] [Related]
9. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma. Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468 [TBL] [Abstract][Full Text] [Related]
11. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma. Liu S; Deng X; Zhang J Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117 [TBL] [Abstract][Full Text] [Related]
12. Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence. Zhang J; Ye Y; Chang DW; Lin SH; Huang M; Tannir NM; Matin S; Karam JA; Wood CG; Chen ZN; Wu X Am J Pathol; 2018 Nov; 188(11):2487-2496. PubMed ID: 30201497 [TBL] [Abstract][Full Text] [Related]
13. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1. Butz H; Szabó PM; Khella HW; Nofech-Mozes R; Patocs A; Yousef GM Oncotarget; 2015 May; 6(14):12543-57. PubMed ID: 26002553 [TBL] [Abstract][Full Text] [Related]
14. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma. Friedrich M; Heimer N; Stoehr C; Steven A; Wach S; Taubert H; Hartmann A; Seliger B Sci Rep; 2020 Apr; 10(1):6499. PubMed ID: 32300145 [TBL] [Abstract][Full Text] [Related]
15. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679 [TBL] [Abstract][Full Text] [Related]
16. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5. Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer. Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929 [TBL] [Abstract][Full Text] [Related]